FDA inspection
Acadia Pharmaceuticals Inc.: FDA inspection ending Jan 27, 2021
FDA inspection 1135361 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 1135361 |
|---|---|
| Firm | Acadia Pharmaceuticals Inc. |
| FEI number | 3005617555 |
| Address | 12830 El Camino Real, Suite 400 |
| City | San Diego |
| State | CA |
| ZIP | 92130 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Jan 27, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data